Live Breaking News & Updates on Merrimack Pharmaceuticals Inc

Stay updated with breaking news from Merrimack pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Increases Dividend to $15.10 Per Share

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) announced a dividend on Thursday, May 16th, investing.com reports. Shareholders of record on Tuesday, May 21st will be paid a dividend of 15.10 per share by the biopharmaceutical company on Friday, May 17th. This represents a yield of 99.87%. The ex-dividend date is Monday, May 20th. This […] ....

United States , United Kingdom , News Ratings For Merrimack Pharmaceuticals Daily , Merrimack Pharmaceuticals Company Profile , Merrimack Pharmaceuticals Stock Performance , Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Inc , Get Free Report , Merrimack Pharmaceuticals Daily ,

Merrimack Pharmaceuticals (NASDAQ:MACK) Cut to "Sell" at StockNews.com

StockNews.com cut shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Free Report) from a hold rating to a sell rating in a research report released on Monday morning. Merrimack Pharmaceuticals Trading Up 0.1 % Merrimack Pharmaceuticals stock opened at $15.13 on Monday. The firm has a market capitalization of $219.84 million, a P/E ratio of -189.13 and […] ....

United States , United Kingdom , Wittenberg Investment Management Inc , Kennedy Capital Management , Merrimack Pharmaceuticals Trading , Hedge Funds Weigh In On Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Inc , Aristides Capital , Merrimack Pharmaceuticals Increases Dividend , Merrimack Pharmaceuticals , News Ratings For Merrimack Pharmaceuticals Daily , Free Report , Get Free Report , Financial Markets , Capital Management , Investment Management , Merrimack Pharmaceuticals Daily ,

Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock

Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Gary Crocker , Drug Administration , Exchange Commission , Merrimack Pharmaceuticals Inc , Merrimack Pharmaceuticals , Special Meeting , Common Stock , Elevation Oncology , Securities Litigation Reform Act , Merrimack Board , Annual Report ,

Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock

Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Gary Crocker , Drug Administration , Exchange Commission , Merrimack Pharmaceuticals Inc , Announces Stockholder Approval , Dissolution And Cash Liquidating Dividend Amount , Special Meeting , Common Stock , Elevation Oncology , Securities Litigation Reform Act , Merrimack Board , Annual Report ,

Merrimack Pharmaceuticals Plans Liquidating Dividend

Merrimack Pharmaceuticals Plans Liquidating Dividend
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Inc ,